DePuy Execs Discussed Failure Rates Found in Clinical Trials

A smoking gun email that was sent 12 months prior to the DePuy ASR recall proves DePuy executives discussed the failure rates well before any decision to recall the device. Considering the contents of the email, sent internally from a DePuy executive, there is a good reason why only one out of the two DePuy ASR hip components was ever sold in the United States.

Please visit our Blog to read the entire story

Experts Urge Metal-on-Metal Hip Recipients to Follow up with Surgeon

As the DePuy ASR litigation develops, the broader category of Metal-on-Metal hip devices is gaining more attention. According to USA Today, an estimated 500,000 people have a metal-on-metal hip implant in the United States. About 40,000 of them were used in the 12-month period from 2005-2006, when MoM implants accounted for about 32% of those used, according to the American Society of Hip and Knee Surgeons.

The use of these devices has decrease drastically since the discovery of higher failure rates and the danger of high metal levels in the bloodstream due to metallic wear. Experts like Mathias Bostrom, an orthopedic surgeon at the Hospital for Special Surgery in New York City, are now saying that “almost all metal-on-metal implants have issues.” It is important that everyone with a MoM hip device follow up with his or her surgeon

Click here to read the full USA Today article